Huakang Biomedical Holdings Company Limited (HKG:8622)

HKG:8622 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.5	32.94	33.3	36.21	41.94
Short-Term Investments	5	-	-	-	-
Cash & Short-Term Investments	36.5	32.94	33.3	36.21	41.94
Cash Growth	10.81%	-1.10%	-8.02%	-13.68%	-14.04%
Accounts Receivable	9.95	9.68	9.47	9.4	9.5
Other Receivables	0.62	0.25	2.25	2.33	0.83
Receivables	12.16	13.74	15.52	11.73	10.33
Inventory	2.72	3.4	3.12	4.21	2.77
Prepaid Expenses	0.25	0.6	0.26	0.3	1.09
Other Current Assets	3.09	2.77	1.23	1.22	2.88
Total Current Assets	54.72	53.44	53.42	53.66	59.01
Property, Plant & Equipment	9.04	9.75	8.27	10.35	9.69
Long-Term Deferred Charges	1.46	2.13	2.81	3.04	2.92
Other Long-Term Assets	-	-	1.9	-	1.08
Total Assets	65.22	65.32	66.4	67.06	72.7
Accounts Payable	0.66	0.64	0.83	0.72	1.45
Accrued Expenses	4.57	6.79	4.71	3.26	2.77
Short-Term Debt	2.91	2.85	1.41	0.1	-
Current Portion of Leases	1.18	1.11	0.41	1.02	1.41
Current Income Taxes Payable	-	-	-	0.22	0.26
Current Unearned Revenue	0.71	0.57	1.28	2.19	2.19
Other Current Liabilities	1.14	1.14	1.14	1.14	1.19
Total Current Liabilities	11.17	13.1	9.78	8.64	9.27
Long-Term Leases	-	1.18	0.06	0.67	1.24
Long-Term Unearned Revenue	0.01	0.02	0.04	0.05	0.34
Total Liabilities	11.17	14.3	9.88	9.36	10.84
Common Stock	4.43	3.67	3.64	3.51	3.51
Additional Paid-In Capital	57	50.26	49.43	47.25	47.25
Retained Earnings	-10.57	-6.41	-0.63	2.45	6.46
Comprehensive Income & Other	3.19	3.49	4.09	4.5	4.64
Shareholders' Equity	54.05	51.02	56.52	57.71	61.86
Total Liabilities & Equity	65.22	65.32	66.4	67.06	72.7
Total Debt	4.08	5.14	1.88	1.79	2.64
Net Cash (Debt)	32.41	27.8	31.43	34.42	39.3
Net Cash Growth	16.59%	-11.54%	-8.70%	-12.42%	-16.70%
Net Cash Per Share	0.07	0.07	0.08	0.09	0.10
Filing Date Shares Outstanding	500.47	418.47	414.47	400	400
Total Common Shares Outstanding	500.47	418.47	414.47	400	400
Working Capital	43.56	40.34	43.64	45.03	49.74
Book Value Per Share	0.11	0.12	0.14	0.14	0.15
Tangible Book Value	54.05	51.02	56.52	57.71	61.86
Tangible Book Value Per Share	0.11	0.12	0.14	0.14	0.15
Machinery	17.17	15.78	14.67	14.18	11.6
Construction In Progress	-	-	-	-	0.4
Leasehold Improvements	5.89	5.34	5.74	5.57	4.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.